US Broker Ratings

Vaxcyte, Inc. (PCVX) Stock Analysis: A Biotech Contender with a Promising 286% Upside

Vaxcyte, Inc. (PCVX), a clinical-stage biotech company based in San Carlos, California, is setting the stage for significant market interest with a robust pipeline focused on innovative vaccine solutions for..

Alkermes plc (ALKS) Stock Analysis: Potential 42% Upside Amidst Strategic Developments

Alkermes plc (NASDAQ: ALKS), headquartered in Dublin, Ireland, stands at the forefront of the biopharmaceutical industry, specifically within the specialties of drug manufacturing for both generic and proprietary products. With..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 62% Potential Upside in the Biotech Sector

ADMA Biologics Inc (NASDAQ: ADMA) presents an intriguing opportunity for investors seeking exposure in the biotechnology sector. With a market capitalization of $4.34 billion, this U.S.-based company is making waves..

GSK plc (GSK) Stock Analysis: Exploring a 7.66% Upside Potential for Investors

GSK plc (NYSE: GSK), a titan in the healthcare sector, continues to draw attention from investors with its robust market presence and promising growth prospects. With a market capitalization of..

Blueprint Medicines Corporation (BPMC) Stock Analysis: Navigating the Biotech Growth with a 55.5% Revenue Surge

As the biotechnology sector continues to evolve, Blueprint Medicines Corporation (NASDAQ: BPMC) stands out with its innovative approach to precision therapies for genomically defined cancers and blood disorders. With a..

Elanco Animal Health (ELAN) Stock Analysis: Exploring Growth Potential with a 4% Upside

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a significant player in the healthcare sector, specifically within the niche of drug manufacturers focusing on both specialty and generic products. With..

Tenet Healthcare Corporation (THC) Stock Analysis: Evaluating the 7.60% Potential Upside

Investors eyeing Tenet Healthcare Corporation (NYSE: THC) may find compelling opportunities as the company positions itself within the dynamic healthcare sector. With a market cap of $16.13 billion, Tenet stands..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a 28.84% Potential Upside Amid Mixed Financial Signals

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the medical devices industry, offers a complex investment landscape as it navigates through mixed financial signals. With a market capitalization of..

Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 9.39% Potential Upside in the Healthcare Sector

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands out as a compelling player in the healthcare sector, particularly within the niche of over-the-counter (OTC) health and personal care products. With a..

Exelixis, Inc. (EXEL) Stock Analysis: Riding the Wave of 30.60% Revenue Growth in the Biotechnology Sphere

Exelixis, Inc. (NASDAQ: EXEL) stands out in the biotechnology industry with its robust focus on oncology, seeking to address some of the most challenging cancers. With a market capitalization of..

Charles River Laboratories (CRL) Stock Analysis: Navigating Healthcare’s Dynamic Landscape with a 4.09% Potential Upside

Charles River Laboratories International, Inc. (NYSE: CRL), a stalwart in the healthcare sector’s diagnostics and research industry, presents an intriguing case for investors navigating the current market landscape. With its..

Teleflex Incorporated (TFX) Stock Analysis: Exploring a 30.51% Potential Upside

Teleflex Incorporated (NYSE: TFX), a leader in medical instruments and supplies, presents a compelling investment case within the healthcare sector. As a company that has been pioneering in the design..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 29% Upside Potential in the Healthcare Sector

Bruker Corporation (NASDAQ: BRKR) stands as a formidable player within the healthcare sector, specializing in medical devices and scientific instruments. With a diverse portfolio that includes everything from magnetic resonance..

Option Care Health, Inc. (OPCH) Stock Analysis: Unlocking a 19.55% Upside Potential

As the healthcare landscape continues to evolve, Option Care Health, Inc. (NASDAQ: OPCH) presents a compelling investment opportunity with its strong market positioning in the medical care facilities industry. Headquartered..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: A 40% Upside Amid Biotech Innovations

Madrigal Pharmaceuticals, Inc. (MDGL), a key player in the biotechnology sector, has garnered significant attention from investors with its innovative approach to tackling metabolic dysfunction-associated steatohepatitis (MASH). With a market..

Nuvalent, Inc. (NUVL) Investor Outlook: Biotechnology Innovator with Potential 48.93% Upside

Nuvalent, Inc. (NASDAQ: NUVL) is making waves in the biotechnology sector, capturing investor attention with its promising pipeline of cancer therapies and a substantial potential upside of nearly 49%. Headquartered..

Regencell Bioscience Holdings (RGC): Investor Outlook as Stock Rebounds to $17.4 Amid Volatility

Regencell Bioscience Holdings Limited (RGC), a Hong Kong-based bioscience company, has recently captured the attention of individual investors with its dramatic stock price movements. Specializing in Traditional Chinese Medicine (TCM)..

Rhythm Pharmaceuticals (RYTM) Investor Outlook: Exploring a 32.98% Potential Upside in Biotechnology

For investors eyeing opportunities in the healthcare sector, particularly within the biotechnology industry, Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) presents a compelling case. With a market capitalization of $3.99 billion, this..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 75% Upside Potential with Strong Buy Ratings

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a biopharmaceutical powerhouse based in Dublin, Ireland, operates within the dynamic healthcare sector, specifically in biotechnology. With a market capitalization of $6.47 billion, Jazz Pharmaceuticals..

Viatris Inc. (VTRS) Stock Analysis: Exploring a Potential 26% Upside Amidst Volatility

Viatris Inc. (NASDAQ: VTRS) is a prominent player in the healthcare sector, specifically within the drug manufacturing industry, focusing on both specialty and generic pharmaceuticals. Despite the current market volatility,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds